Butylphthalide, CAS:6066-49-5
MF:C12H14O2
Purpose:Used for the treatment of acute ischemic cerebrovascular disease (such as cerebral infarction).
Classification :
PRODUCT DETAILS
Specifications | |
Product Name | Butylphthalide |
CAS No. | 6066-49-5 |
Test Standard | Enterprise standard |
| |
Items | Standard |
Appearance | Colorless to light yellow oily liquid,with a characteristic odor |
Identification | HPLC: the retention time of the principal peak is similar to the reference spectrum |
Solubility: | Very soluble in methanol, acetonitrile, ethanol and dichloromethane, practically insoluble in water |
Loss on drying | ≤0.5% |
Heavy metals | ≤20ppm |
Related Substance | Single impurity≤0.2% |
Total impurities≤1.0% | |
Purity | ≥99.0% |
Packaging | Inner packaging:HDPE bottle, Outer packaging:cardboard drum, |
Storage Conditions | Light-proof, airtight, cool, dry & ventilated place. |
HOT PRODUCTS
(R)-(+)-3-Chloro-1-Phenyl-1-Propanol,CAS#100306-33-0
2-(2'-hydroxy-3'-methallyl-5'-methylphenyl)benzotriazole,CAS#98809-58-6
(S)-4-(3-chloro-4-MethoxybenzylaMino)-5-ethoxycarbonyl-2-(2-hydroxyMethyl-1-pyrrolidinyl)pyriMidine,CAS#330785-83-6
(S)-4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid,CAS#330785-84-7
Dapoxetine,CAS#119356-77-3
2',4'-Dihydroxyacetophenone,CAS#89-84-9
Bazedoxifene Acetate,CAS#198481-33-3
Vardenafil hydrochloride trihydrate,CAS NO.:330808-88-3
Avanafil, CAS:330784-47-9
Bevenopran,CAS:676500-67-7